1. Home
  2. MXCT vs ORMP Comparison

MXCT vs ORMP Comparison

Compare MXCT & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

SELL

Current Price

$1.38

Market Cap

155.8M

Sector

Health Care

ML Signal

SELL

Logo Oramed Pharmaceuticals Inc.

ORMP

Oramed Pharmaceuticals Inc.

SELL

Current Price

$3.61

Market Cap

160.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MXCT
ORMP
Founded
1999
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
155.8M
160.6M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
MXCT
ORMP
Price
$1.38
$3.61
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
★ $4.11
N/A
AVG Volume (30 Days)
★ 1.4M
117.4K
Earning Date
11-10-2026
11-12-2026
Dividend Yield
N/A
★ 6.78%
EPS Growth
N/A
★ 412.50
EPS
N/A
★ 3.17
Revenue
★ $33,026,000.00
$2,000,000.00
Revenue This Year
$4.77
N/A
Revenue Next Year
$10.06
N/A
P/E Ratio
★ N/A
$1.16
Revenue Growth
N/A
★ 49.25
52 Week Low
$0.64
$2.52
52 Week High
$1.80
$5.47

Technical Indicators

Market Signals
Indicator
MXCT
ORMP
Relative Strength Index (RSI) 55.07 32.96
Support Level $1.02 $3.55
Resistance Level $1.54 $3.72
Average True Range (ATR) 0.14 0.20
MACD -0.01 -0.02
Stochastic Oscillator 70.41 9.86

Price Performance

Historical Comparison
MXCT
ORMP

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.

Share on Social Networks: